Your browser doesn't support javascript.
loading
Sustained response to erlotinib and rapamycin in a patient with pediatric anaplastic oligodendroglioma.
Geben, Laura C; Mobley, Bret C; Brockman, Asa A; Pastakia, Devang; Naftel, Rob; Ihrie, Rebecca A; Esbenshade, Adam J.
  • Geben LC; Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Mobley BC; Program in Pharmacology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Brockman AA; Departments of Pathology, Microbiology, & Immunology, Vanderbilt University Medical Center, Nashville, Tennessee.
  • Pastakia D; Vanderbilt Ingram Cancer Center, Nashville, Tennessee.
  • Naftel R; Department of Cell & Developmental Biology, Vanderbilt University School of Medicine, Nashville, Tennessee.
  • Ihrie RA; Monroe Carell Jr. Children's Hospital at Vanderbilt, Division of Pediatric Hematology-Oncology, Nashville, Tennessee.
  • Esbenshade AJ; Departments of Pediatrics, Vanderbilt University Medical Center, Nashville, Tennessee.
Pediatr Blood Cancer ; 68(1): e28750, 2021 01.
Article en En | MEDLINE | ID: mdl-33001573
Asunto(s)
Palabras clave
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligodendroglioma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Prognostic_studies Límite: Child / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article
Texto completo
Imprimir
XML
PubMed Links
Search on Google

Texto completo: 1 Banco de datos: MEDLINE Asunto principal: Oligodendroglioma / Protocolos de Quimioterapia Combinada Antineoplásica Tipo de estudio: Prognostic_studies Límite: Child / Female / Humans Idioma: En Año: 2021 Tipo del documento: Article